Feeling constantly tired despite getting enough sleep? Chronic exhaustion is common but often treatable. In this New York Times article, AACE President, Susan L. Samson, MD, PhD, FRCPC, FACE,…
Appointments with health professionals for obesity drug consultations are way up, according to data from Zocdoc, a provider of scheduling services. AACE President Elect, Scott D. Isaacs, MD, FACP,…
As we’re living through global pandemics and various natural disasters, emergency preparedness has taken on a whole new significance. While emergency…
As the use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) continues to exponentially expand obesity treatment, concerns have arisen regarding their impact on nutrition in people who take…
Patient SummaryAACE Clinical Practice Guideline forPharmacologic Management of Persons with Dyslipidemia (High Cholesterol and Triglycerides)
Heart disease is a leading cause of death worldwide.…
AACE members Shailendra B. Patel, BM, ChB, DPhil, and Kathleen L. Wyne, MD, PhD, provide insights on the new AACE Clinical Practice Guideline for the Pharmacologic Management of Adults with…
AACE published its first updated guideline on the pharmacologic management of adults with dyslipidemia since 2017, incorporating new recommendations for recently approved medications. Developed using…
Dr. Carol H. Wysham interviews AACE President, Scott D. Isaacs, MD, FACP, FACE, on the Medscape InDiscussion: Type 2 Diabetes (Season 3) podcast to discuss the screening and management of…
Eli Lilly has reduced the prices of certain Zepbound vials and introduced higher-dose options, making the weight-loss drug more accessible. AACE President Scott D. Isaacs, MD, FACP, FACE, and AACE…
Machine learning may help identify biomarkers and develop predictive models that could assist in the diagnosis of metabolic dysfunction-associated steatotic liver disease (MASLD) and hepatic fibrosis…